Cerity Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.4M | Buy |
21,170
+2,540
| +14% | +$1.36M | 0.02% | 493 |
|
2025
Q1 | $7.82M | Buy |
18,630
+7,235
| +63% | +$3.04M | 0.02% | 572 |
|
2024
Q4 | $5.07M | Buy |
11,395
+471
| +4% | +$210K | 0.01% | 708 |
|
2024
Q3 | $5.52M | Buy |
10,924
+2,202
| +25% | +$1.11M | 0.01% | 663 |
|
2024
Q2 | $4.25M | Sell |
8,722
-4,379
| -33% | -$2.13M | 0.01% | 652 |
|
2024
Q1 | $7.07M | Buy |
13,101
+6,641
| +103% | +$3.59M | 0.02% | 555 |
|
2023
Q4 | $3.59M | Buy |
6,460
+1,409
| +28% | +$782K | 0.01% | 609 |
|
2023
Q3 | $2.21M | Sell |
5,051
-4,340
| -46% | -$1.9M | 0.01% | 560 |
|
2023
Q2 | $4.72M | Buy |
9,391
+837
| +10% | +$420K | 0.02% | 509 |
|
2023
Q1 | $5.09M | Buy |
8,554
+752
| +10% | +$447K | 0.01% | 494 |
|
2022
Q4 | $3.18M | Buy |
7,802
+4,904
| +169% | +$2M | 0.02% | 447 |
|
2022
Q3 | $944K | Sell |
2,898
-125
| -4% | -$40.7K | 0.01% | 531 |
|
2022
Q2 | $1.06M | Buy |
3,023
+1,591
| +111% | +$558K | 0.01% | 535 |
|
2022
Q1 | $386K | Buy |
1,432
+697
| +95% | +$188K | 0.01% | 655 |
|
2021
Q4 | $488K | Buy |
+735
| New | +$488K | 0.01% | 604 |
|
2021
Q3 | – | Sell |
-606
| Closed | -$383K | – | 704 |
|
2021
Q2 | $383K | Sell |
606
-55
| -8% | -$34.8K | 0.01% | 518 |
|
2021
Q1 | $323K | Buy |
+661
| New | +$323K | 0.01% | 535 |
|
2019
Q2 | – | Sell |
-1,075
| Closed | -$240K | – | 532 |
|
2019
Q1 | $240K | Buy |
+1,075
| New | +$240K | 0.02% | 460 |
|
2018
Q4 | – | Sell |
-944
| Closed | -$236K | – | 531 |
|
2018
Q3 | $236K | Buy |
+944
| New | +$236K | 0.02% | 479 |
|